PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
PulseAugur coverage of PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer — every cluster mentioning PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer across labs, papers, and developer communities, ranked by signal.
No coverage in the last 90 days.
-
Deep learning predicts breast cancer subtypes from pathology images
Researchers have developed a new deep learning framework to classify breast cancer subtypes using histopathology images, potentially reducing the need for costly molecular assays. The method employs a multi-objective pa…
-
New CMGL framework improves cancer subtype classification using multi-omics data
Researchers have developed CMGL, a novel two-stage framework for cancer subtype classification that integrates multi-omics data. This method addresses challenges posed by varying data quality and noise across different …
-
CMGL framework improves cancer subtype classification using confidence-guided multi-omics graph learning
Researchers have developed CMGL, a novel framework for cancer subtype classification that leverages multi-omics data. This two-stage approach first estimates the reliability of different omics modalities for each patien…